Penumbra
PEN
$272.26
Share price
0.74%
Change (1 day)
29.53%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Net assets
Net assets on the balance sheet as of December 2024 : $1.15 Billion USD
According to Penumbra's latest financial reports the company has $1.15 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Penumbra - Net assets on balance sheet (from 2014 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$1.15 B | -2.38% |
| 2023-12-31 | $$1.17 B | 18.03% |
| 2022-12-31 | $$0.99 B | 4.71% |
| 2021-12-31 | $$0.95 B | 49.57% |
| 2020-12-31 | $$0.63 B | 31.34% |
| 2019-12-31 | $$0.48 B | 14.96% |
| 2018-12-31 | $$0.42 B | 5.5% |
| 2017-12-31 | $$0.40 B | 50.22% |
| 2016-12-31 | $$0.26 B | 14.63% |
| 2015-12-31 | $$0.23 B | -1979.73% |
| 2014-12-31 | $-$12.37 Million | 53.44% |
| 2013-12-31 | $-$8.07 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | $0.43 B | -62.23% | 🇺🇸 USA |
 | $1.37 B | 19.85% | 🇺🇸 USA |